<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(6)</volume><submitter>Ambrosio G</submitter><pubmed_abstract>Ecdysterone is a phytosteroid widely discussed for its various pharmacological, growth-promoting, and anabolic effects, mediated by the activation of estrogen receptor beta (ERbeta). Performance-enhancement in sports was demonstrated recently, and ecdysterone was consequently included in the Monitoring Program, to detect potential patterns of misuse in sport. Only few studies on the pharmacokinetics of ecdysterone in humans have been reported so far. In this study, post-administration urine samples in twelve volunteers (single dose of 50 mg of ecdysterone) were analyzed using dilute-and-inject liquid-chromatography-tandem mass spectrometry. Identification and quantitation of ecdysterone and of two metabolites, 14-deoxy-ecdysterone and 14-deoxy-poststerone, was achieved. Ecdysterone was the</pubmed_abstract><journal>Metabolites</journal><pagination>366</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8227119</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Urinary Elimination of Ecdysterone and Its Metabolites Following a Single-Dose Administration in Humans.</pubmed_title><pmcid>PMC8227119</pmcid><pubmed_authors>Wuest B</pubmed_authors><pubmed_authors>Isenmann E</pubmed_authors><pubmed_authors>Yuliandra T</pubmed_authors><pubmed_authors>Mazzarino M</pubmed_authors><pubmed_authors>Diel P</pubmed_authors><pubmed_authors>de la Torre X</pubmed_authors><pubmed_authors>Botre F</pubmed_authors><pubmed_authors>Parr MK</pubmed_authors><pubmed_authors>Ambrosio G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Urinary Elimination of Ecdysterone and Its Metabolites Following a Single-Dose Administration in Humans.</name><description>Ecdysterone is a phytosteroid widely discussed for its various pharmacological, growth-promoting, and anabolic effects, mediated by the activation of estrogen receptor beta (ERbeta). Performance-enhancement in sports was demonstrated recently, and ecdysterone was consequently included in the Monitoring Program, to detect potential patterns of misuse in sport. Only few studies on the pharmacokinetics of ecdysterone in humans have been reported so far. In this study, post-administration urine samples in twelve volunteers (single dose of 50 mg of ecdysterone) were analyzed using dilute-and-inject liquid-chromatography-tandem mass spectrometry. Identification and quantitation of ecdysterone and of two metabolites, 14-deoxy-ecdysterone and 14-deoxy-poststerone, was achieved. Ecdysterone was the</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-05-31T23:33:27.487Z</modification><creation>2025-05-31T23:33:27.487Z</creation></dates><accession>S-EPMC8227119</accession><cross_references><pubmed>34207569</pubmed><doi>10.3390/metabo11060366</doi></cross_references></HashMap>